Poly(ethylene glycol)-block-poly(2-methyl-2-benzoxycarbonyl-propylene carbonate) micelles for rapamycin delivery: In vitro characterization and biodistribution

Journal of Pharmaceutical Sciences

Volumn 100, Issue 6, 2011, Pages 2418-2429

  Lu, Wenli ^a   Li, Feng ^a   Mahato, Ram I ^a  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

Biodistribution; Micelles; Nanosuspensions; Poly(ethylene glycol) block poly(2 methyl 2 benzoxycarbonyl propylene carbonate); Rapamycin

Indexed keywords

1,8 DIAZABICYCLOUNDEC 7 ENE; COPOLYMER; MACROGOL; POLY(2 METHYL 2 BENZOXYCARBONYLPROPYLENE CARBONATE); RAPAMYCIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CATALYST; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; HUMAN; HUMAN CELL; HUMAN TISSUE; INSULINOMA; MICELLE; MOUSE; NONHUMAN; PANCREAS ISLET CELL; RAT; RING OPENING METATHESIS POLYMERIZATION;

EID: 79954599140     PISSN: 00223549     EISSN: 15206017     Source Type: Journal    
DOI: 10.1002/jps.22467     Document Type: Article

References (34)

1. Shapiro AM, Lakey JR, Ryan EA, Korbutt GS, Toth E, Warnock GL, Kneteman NM, Rajotte RV. 2000. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N Engl J Med 343(4):230-238.
2. Goss JA, Schock AP, Brunicardi FC, Goodpastor SE, Garber AJ, Soltes G, Barth M, Froud T, Alejandro R, Ricordi C. 2002. Achievement of insulin independence in three consecutive type-1 diabetic patients via pancreatic islet transplantation using islets isolated at a remote islet isolation center. Transplantation 74(12):1761-1766.
3. Ryan EA, Paty BW, Senior PA, Bigam D, Alfadhli E, Kneteman NM, Lakey JR, Shapiro AM. 2005. Five-year follow-up after clinical islet transplantation. Diabetes 54(7):2060-2069.
4. Bell E, Cao X, Moibi JA, Greene SR, Young R, Trucco M, Gao Z, Matschinsky FM, Deng S, Markman JF, Naji A, Wolf BA. 2003. Rapamycin has a deleterious effect on MIN-6 cells and rat and human islets. Diabetes 52(11):2731-2739.
5. Paty BW, Harmon JS, Marsh CL, Robertson RP. 2002. Inhibitory effects of immunosuppressive drugs on insulin secretion from HIT-T15 cells and Wistar rat islets. Transplantation 73(3):353-357.
6. Larsen JL, Bennett RG, Burkman T, Ramirez AL, Yamamoto S, Gulizia J, Radio S, Hamel FG. 2006. Tacrolimus and sirolimus cause insulin resistance in normal sprague dawley rats. Transplantation 82(4):466-470.
7. Sehgal SN. 2003. Sirolimus: its discovery, biological properties, and mechanism of action. Transplant Proc 35(3 Suppl):7S-14S.
8. Simamora P, Alvarez JM, Yalkowsky SH. 2001. Solubilization of rapamycin. Int J Pharm 213(1-2):25-29.
9. Yanez JA, Forrest ML, Ohgami Y, Kwon GS, Davies NM. 2008. Pharmacometrics and delivery of novel nanoformulated PEG-b-poly(epsilon-caprolactone) micelles of rapamycin. Cancer Chemother Pharmacol 61(1):133-144.
10. Hennenfent KL, Govindan R. 2006. Novel formulations of taxanes: A review. Old wine in a new bottle? Ann Oncol 17(5):735-749.
11. Gaucher G, Marchessault RH, Leroux JC. 2010. Polyester-based micelles and nanoparticles for the parenteral delivery of taxanes. J Control Release 143(1):2-12.
12. Ramaswamy M, Zhang X, Burt HM, Wasan KM. 1997. Human plasma distribution of free paclitaxel and paclitaxel associated with diblock copolymers. J Pharm Sci 86(4):460-464.
13. Liu J, Zeng F, Allen C. 2007. In vivo fate of unimers and micelles of a poly(ethylene glycol)-block-poly(caprolactone) copolymer in mice following intravenous administration. Eur J Pharm Biopharm 65(3):309-319.
14. Yoo HS, Park TG. 2001. Biodegradable polymeric micelles composed of doxorubicin conjugated PLGA-PEG block copolymer. J Control Release 70(1-2):63-70.
15. Danquah M, Li F, Duke CB, Miller DD, Mahato RI. 2009. Micellar delivery of bicalutamide and embelin for treating prostate cancer. Pharm Res 26(9):2081-2092.
16. Danquah M, Fujiwara T, Mahato RI. 2010. Self-assembling methoxypoly(ethylene glycol)-b-poly(carbonate-co-L-lactide) block copolymers for drug delivery. Biomaterials 31(8):2358-2370.
17. Li F, Danquah M, RI M. 2010. Synthesis and characterization of amphiphilic lipopolymers for micellar drug delivery. Biomacromolecules 11(10):2610-2620.
18. Li F, Lu Y, Li W, Miller DD, Mahato RI. 2010. Synthesis, formulation and in vitro evaluation of a novel microtubule destabilizer, SMART-100. J Control Release 143(1):151-158.
19. Gao J, Ming J, He B, Fan Y, Gu Z, Zhang X. 2008. Preparation and characterization of novel polymeric micelles for 9-nitro-20(S)-camptothecin delivery. Eur J Pharm Sci 34(2-3):85-93.
20. Ricciutelli M, Di Martino P, Barboni L, Martelli S. 2006. Evaluation of rapamycin chemical stability in volatile-organic solvents by HPLC. J Pharm Biomed Anal 41(3):1070-1074.
21. Gallo R, Padurean A, Jayaraman T, Marx S, Roque M, Adelman S, Chesebro J, Fallon J, Fuster V, Marks A, Badimon JJ. 1999. Inhibition of intimal thickening after balloon angioplasty in porcine coronary arteries by targeting regulators of the cell cycle. Circulation 99(16):2164-2170.
22. Campanero MA, Cardenas E, Sadaba B, Garcia-Quetglas E, Munoz-Juarez MJ, Gil-Aldea I, Pazo D, Azanza JR, Honorato J. 2004. Therapeutic drug monitoring for sirolimus in whole blood of organ transplants by high-performance liquid chromatography with ultraviolet detection. J Chromatogr A 1031(1-2):265-273.
23. Allen C, Maysinger D, Eisenberg A. 1999. Nanoengineering block copolymer aggregates for drug delivery. Colloids Surf B Biointerfaces 16(1-4):3-27.
24. Mahmud A, Patel S, Molavi O, Choi P, Samuel J, Lavasanifar A. 2009. Self-associating poly(ethylene oxide)-b-poly(alpha-cholesteryl carboxylate-epsilon-caprolactone) block copolymer for the solubilization of STAT-3 inhibitor cucurbitacin I. Biomacromolecules 10(3):471-478.
25. Kim SY, Shin IG, Lee YM, Cho CS, Sung YK. 1998. Methoxy poly(ethylene glycol) and epsilon-caprolactone amphiphilic block copolymeric micelle containing indomethacin. II. Micelle formation and drug release behaviors. J Control Release 51(1):13-22.
26. Cheon Lee S, Kim C, Chan Kwon I, Chung H, Young Jeong S. 2003. Polymeric micelles of poly(2-ethyl-2-oxazoline)-block-poly(epsilon-caprolactone) copolymer as a carrier for paclitaxel. J Control Release 89(3):437-446.
27. Allen C, Maysinger D, Eisenberg A. 1999. Nanoengineering block copolymer aggregates for drug delivery. Colloids Surf B Biointerfaces 16:3-27.
28. Nishioka Y, Yoshino H. 2001. Lymphatic targeting with nanoparticulate system. Adv Drug Deliv Rev 47(1):55-64.
29. Hawley AE, Davis SS, Illum L. 1995. Targeting of colloids to lymph nodes: influence of lymphatic physiology and colloidal characteristics. Adv Drug Deliv Rev 17(1):129-148.
30. Borhade V, Nair H, Hegde D. 2008. Design and evaluation of self-microemulsifying drug delivery system (SMEDDS) of tacrolimus. AAPS PharmSciTech 9(1):13-21.
31. Ikomi F, Hanna GK, Schmid-Schonbein GW. 1995. Mechanism of colloidal particle uptake into the lymphatic system: Basic study with percutaneous lymphography. Radiology 196(1):107-113.
32. Uno T, Kazui T, Suzuki Y, Hashimoto H, Suzuki K, Muhammad BA. 1999. Pharmacokinetic advantages of a newly developed tacrolimus oil-in-water-type emulsion via the enteral route. Lipids 34(3):249-254.
33. Shin SB, Cho HY, Kim DD, Choi HG, Lee YB. 2010. Preparation and evaluation of tacrolimus-loaded nanoparticles for lymphatic delivery. Eur J Pharm Biopharm 74(2):164-171.
34. Rabinow BE. 2004. Nanosuspensions in drug delivery. Nat Rev Drug Discov 3(9):785-796.